<unk>  is a common metabolic disorder charaterized by  increase in cholesterol and/or triglycerides in at least two members of the family, variable  intra-individual and intrafamilial lipid phenotype, and increased risk of premature coronary heart disease. Several theories have been postulated about the development of<unk> . Its prevalence is estimated to be 0.5-2% in general population annually.
Familial combined hyperlipidemia
Familial hypercholesterolemia
Primary hypertriglyceridemia
Hyperlipoproteinemia type II
Hyperlipoproteinemia type 5
Apolipoprotein B deficiency
Very low density lipoprotein physiology
Apolipoprotein A deficiency